| 11-1474A | Accountability for Cancer Care through Undoing Racism and Equity (ACCURE) | Open |
| 13-2058 | Internet Tobacco Vendors Youth Purchase Survey | Open |
| 15-3137 | A Feasibility Study of Antineoplastic Drug Exposure among Nursing Assistants | Open |
| 17-1493 | Expanded Access of Neratinib for Use with Capecitabine in Patients with Metastatic Breast Cancer and CNS Metastasis | Open (affiliates only) |
| A031102-CIRB | A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (Tip) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed By High-Dose Carboplatin And Etoposide (Ti-Ce) As First Salvage Treatment in Relapsed or Refractory Germ Cell
Tumors
| Open |
| AALL0331 | Standard Risk B-precursor Acute Lymphoblastic Leukemia | Open |
| AMGEN359 | A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of
Denosumab as Adjuvant Treatment for Women with Early-Stage Breast Cancer at High Risk of
Recurrence (D-CARE) | Open (affiliates only) |
| AMGEN482 | A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With
Zoledronic Acid in the Treatment of Bone Disease in Subjects With Newly
Diagnosed Multiple Myeloma | Open (affiliates only) |
| ASG-22CE-13-2 | A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of
ASG-22CE Given as Monotherapy in Subjects with Metastatic Urothelial
Cancer and Other Malignant Solid Tumors that Express Nectin-4 | Open |
| CALGB90601-CIRB | A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma | Open (affiliates only) |
| J1651 | Phase 2 Study of Azacitidine (AZA) in Combination with Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients and in Newly Diagnosed Older (>65 Years) AML Patients | Open |
| LCCC1241 | Complementary and Alternative medicine use at UNC clinics | Open |
| LCCC1527 | Evaluation of the Chemotherapy Toxicity Risk Score for Treatment Decision in Elderly Patients with Advanced Solid Cancer | Open |
| LCCC1715 | Detection and Analysis of MERTK in Cancer Patients | Open |
| MM-398-01-01-02 | A Phase 1 Study in Patients Treated with MM-398 (Nanoliposomal Irinotecan, nal-IRI,) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment | Open |
| MSKCC-13-074 | Randomized phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) vs. bleomycin, etoposide and cisplatin (BEP) for patients with previously untreated intermediate- and poor- risk germ cell tumors | Open |
| PCRC-14-07 | Caregiver-‐guided pain management training in palliative care | Open |
| RETROSHAVE | Comparison of surgical techniques for obtaining negative margins in patients with breast cancer | Open |
| RTOG1008 | A Randomized Phase II/III Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
| Open |
| TBCRC038 | Diversity in the Tumor Genome and Microenvironment as Drivers of DCIS
Progression | Open |
| TEST4 | A four part, Phase I Dose-Escalation Study of the Combinations of Concurrent BKM120 and Capecitabine,or Concurrent BKM120 and Capecitabine and Trastuzumab, in Patients with Metastatic Colon Cancer (Test4) | Open |